Tralokinumab-ldrm (Adbry) is now approved for the treatment of moderate to severe atopic dermatitis in adults whose disease has not been controlled by topical therapies. Nurses and NPs should teach patients how to administer the drug subcutaneously and that more than one injection is needed to fulfill the prescribed dose.
机构:
Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA
Icahn Sch Med Mt Sinai, Dept Preventat Med, Mt Sinai St Lukes, New York, NY USA
Icahn Sch Med Mt Sinai, Dept Med Social Sci, Mt Sinai St Lukes, New York, NY USANorthwestern Univ, Dept Dermatol, Chicago, IL 60611 USA
Silverberg, Jonathan
Garg, Nitin
论文数: 0引用数: 0
h-index: 0
机构:
Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USANorthwestern Univ, Dept Dermatol, Chicago, IL 60611 USA
Garg, Nitin
Silverberg, Nanette B.
论文数: 0引用数: 0
h-index: 0
机构:
Icahn Sch Med Mt Sinai, Dept Dermatol, Mt Sinai St Lukes, New York, NY USANorthwestern Univ, Dept Dermatol, Chicago, IL 60611 USA
机构:
Childrens Hosp Los Angeles, Div Clin Immunol & Allergy, Los Angeles, CA 90027 USA
Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USAChildrens Hosp Los Angeles, Div Clin Immunol & Allergy, Los Angeles, CA 90027 USA